Coagulation assessment by rotation thrombelastometry in normal pregnancy

Cyril Huissoud; Nicolas Carrabin; Mehdi Benchaib; Oriane Fontaine; Albrice Levrat; Denis Massignon; Sandrine Touzet; René-Charles Rudigoz; Michel Berland

doi:10.1160/TH08-06-0386

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2009; 101(04): 755-761
DOI: 10.1160/TH08-06-0386

New Technologies, Diagnostic Tools and Drugs

Schattauer GmbH

Coagulation assessment by rotation thrombelastometry in normal pregnancy

Authors

Cyril Huissoud

¹Department of Obstetrics and Gynecology, Croix Rousse University Hospital, Lyon, Hospices civils de Lyon, France

²INSERM U846, Stem Cell and Brain Research Institute, Bron, Université de Lyon 1, UMR-S 846, Lyon, France
Nicolas Carrabin

¹Department of Obstetrics and Gynecology, Croix Rousse University Hospital, Lyon, Hospices civils de Lyon, France
Mehdi Benchaib

³Human Assisted Reproduction Laboratory, Hôpital Femme-Mère-Enfant, Bron Cedex, France

⁴Claude Bernard University, University of Lyon, University Lyon 1, France
Oriane Fontaine

⁵Intensive Care and EMS, Edouard Herriot University Hospital, Hospices civils de Lyon, Lyon, France
Albrice Levrat

⁵Intensive Care and EMS, Edouard Herriot University Hospital, Hospices civils de Lyon, Lyon, France
Denis Massignon

⁶Haemostasis Laboratory, University Hospital Lyon-Sud, Hospices civils de Lyon, France
Sandrine Touzet

⁴Claude Bernard University, University of Lyon, University Lyon 1, France

⁶Haemostasis Laboratory, University Hospital Lyon-Sud, Hospices civils de Lyon, France

⁷Epidemiology, Professional Practices and Healthcare Networks Study Unit, Hospices Civils de Lyon, Pole IMER, Lyon, France
René-Charles Rudigoz

¹Department of Obstetrics and Gynecology, Croix Rousse University Hospital, Lyon, Hospices civils de Lyon, France

⁴Claude Bernard University, University of Lyon, University Lyon 1, France
Michel Berland

⁴Claude Bernard University, University of Lyon, University Lyon 1, France

⁸Department of Obstetrics and Gynecology, University Hospital Lyon-Sud, Hospices civils de Lyon, France

Abstract

Summary

We analysed changes in coagulation during normal pregnancy with a novel point-of-care device based on thrombelastometry (ROTEM^®). We compared the results obtained with those of standard coagulation tests in 104 patients: 20 non-pregnant women (controls) and 84 women in the first (T1, n=17), second (T2, n=9) and third (T3, n=58) trimesters of pregnancy. We measured the clotting time (CT), the maximum clot firmness (MCF), the early clot amplitude at 5 and 15 minutes (CA5, CA15) and the clot lysis index (CLI30) with four tests containing specific reagents. (a) The INTEM^® test involving ellagic acid activated the intrinsic pathway and (b) the EXTEM^® test using tissue factor triggered the extrinsic pathway; (c) The FIBTEM^® test based on a platelet inhibitor (cytochalasin D) evaluated the contribution of fibrinogen to clot formation and (d) the APTEM^® test was similar to the EXTEM but was based on inhibition in vitro of fibrinolysis by aprotinin. CT and CLI30 were not significantly modified during pregnancy whereas MCF, CA5 and CA15 (INTEM, EXTEM, FIBTEM) increased significantly between the second and third trimesters (e.g. median [interquartile range]: MCF-FIBTEM, 13 [11–16] mm vs. 19 [17–23] mm, respectively, in controls and T3, p< 0.001). EXTEM values were not significantly different from those measured with APTEM. There were significant correlations between the results obtained with ROTEM and those from standard coagulation tests. ROTEM analysis showed a marked increase in coagulability during normal pregnancy. ROTEM values may serve as the basis for future studies in pregnant women.

Keywords

Thrombelastometry - thrombelastography - pregnancy - hyper-coagulability

Full Text

References

References
1 Holmes VA, Wallace JM. Haemostasis in normal pregnancy: a balancing act?. Biochem Soc Trans 2005; 33: 428-432.
2 Cerneca F, Ricci G, Simeone R. et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 31-36.
3 Uchikova EH, Ledjev II.. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Re-prod Biol 2005; 119: 185-188.
4 Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-114.
5 McColl MD, Ramsay JE, Tait RC. et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183-1188.
6 Bellart J, Gilabert R, Fontcuberta J. et al. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998; 15: 81-85.
7 Bouvier-Colle MH, Deneux C, Szego E. et al. Maternal mortality estimation in France, according to a new method. J Gynecol Obstet Biol Reprod 2004; 33: 421-429.
8 Bouvier-Colle MH, Breart G. Surveillance of maternal mortality in France: why and how?. Gynecol Obstet Fertil 2004; 32: 925-926.
9 Dildy GA. 3rd. Postpartum hemorrhage: new management options. Clin Obstet Gynecol 2002; 45: 330-344.
10 Dailland P. Management and treatment of severe obstetrical hemorrhage. Ann Fr Anesth Reanim 1999; 18: 127-130.
11 Barrowcliffe TW, Cattaneo M, Podda GM. et al. New approaches for measuring coagulation. Haemophilia 2006; 12 (Suppl. 03) 76-81.
12 Chakroun T, Gerotziafas GT, Seghatchian J. et al. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile. Thromb Haemost 2006; 95: 822-828.
13 Kawaguchi C, Takahashi Y, Hanesaka Y. et al. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram. Thromb Haemost 2002; 88: 768-772.
14 Gerotziafas GT, Chakroun T, Samama MM. et al. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile. Thromb Haemost 2004; 92: 1296-1302.
15 Sorensen B, Ingerslev J. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate. Thromb Haemost 2006; 96: 446-453.
16 Savry C, Quinio P, Lefevre F. et al. Manageability and potential for haemostasis monitoring by near-patient modified thromboelastometer (Rotem) in intensive care unit. Ann Fr Anesth Reanim 2005; 24: 607-616.
17 Rugeri L, Levrat A, David JS. et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-295.
18 Coakley M, Reddy K, Mackie I. et al. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20: 548-553.
19 Gorlinger K. Coagulation management during liver transplantation. Hamostaseologie 2006; 26: S64-76.
20 Caen J, Larrieu MJ, Samama M. Temps de cépha-line kaolin. In: L’hémostase. Méthodes d’exploration et diagnostic pratique. Paris: Expansion Scientifique; 1975: 169-170.
21 Caen J, Larrieu MJ, Samama M. Temps de Quick. In: L’hémostase. Méthodes d’exploration et diagnostic pratique. Paris: Expansion Scientifique; 1975: 148-150.
22 Caen J, Larrieu MJ, Samama M. Dosage du fibrinogène. In: L’hémostase. Méthodes d’exploration et diagnostic pratique. Paris: Expansion Scientifique; 1975: 215-216.
23 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
24 Lang T, Bauters A, Braun SL. et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-310.
25 Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-337.
26 Jamain B, Leroux ME, Lambert G. et al. Thrombodynamography (thromboelastography) in obstetrics & gynecology. Characteristics of thrombodynamo-grams & hemostasis in normal pregnant women during labor. Rev Fr Gynecol Obstet 1958; 53: 741-748.
27 Jamain B, Leroux ME, Letessier A. et al. Thrombodynamography (thromboelastography) during pregnancy, labor & the complications of labor. Sem Hop 1959; 35: 1378-1388.
28 Leroux MP, Guimbretiere J, Timmermans C. et al. Thromboelastography during labor and the puerperium. Bull Fed Soc Gynecol Obstet Lang Fr 1961; 13: 203-207.
29 Ciulla U, Malagoli F. Value of thrombelastography in obstetrics. Minerva Med 1963; 54: 215-217.
30 Nikolov N. Thromboelastography and Its Possible Use in Obstetrics. Akush Ginekol (Sofiia) 1964; 3: 14-18.
31 Lang T, von Depka M. Possibilities and limitations of thrombelastometry/-graphy. Hamostaseologie 2006; 26: S20-29.
32 Steer PL, Krantz HB. Thromboelastography and Sonoclot analysis in the healthy parturient. J Clin Anesth 1993; 5: 419-424.
33 Clark P, Brennand J, Conkie JA. et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
34 Kjellberg U, Andersson NE, Rosen S. et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-531.
35 Bellart J, Gilabert R, Angles A. et al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in preeclampsia. Br J Obstet Gynaecol 1999; 106: 594-597.